Cargando…
Genome-scale analysis identifies NEK2, DLGAP5 and ECT2 as promising diagnostic and prognostic biomarkers in human lung cancer
This study aims to identify promising biomarkers for the early detection of lung cancer and evaluate the prognosis of lung cancer patients. Genome-wide mRNA expression data obtained from the Gene Expression Omnibus (GSE19188, GSE18842 and GSE40791), including 231 primary tumor samples and 210 normal...
Autores principales: | Shi, Yuan-Xiang, Yin, Ji-Ye, Shen, Yao, Zhang, Wei, Zhou, Hong-Hao, Liu, Zhao-Qian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5556079/ https://www.ncbi.nlm.nih.gov/pubmed/28808310 http://dx.doi.org/10.1038/s41598-017-08615-5 |
Ejemplares similares
-
NEK2 serves as a prognostic biomarker for hepatocellular carcinoma
por: Li, Gang, et al.
Publicado: (2017) -
Identification and prognostic value of DLGAP5 in endometrial cancer
por: Zheng, Ruoyi, et al.
Publicado: (2020) -
NEK2, a promising target in TP53 mutant cancer
por: Cusan, Martina, et al.
Publicado: (2022) -
ASPM, CDC20, DLGAP5, BUB1B, CDCA8, and NCAPG May Serve as Diagnostic and Prognostic Biomarkers in Endometrial Carcinoma
por: Zhang, Qiaoling, et al.
Publicado: (2022) -
DLGAP4 acts as an effective prognostic predictor for hepatocellular carcinoma and is closely related to tumour progression
por: Dong, Cairong, et al.
Publicado: (2022)